Close

Teva Pharma (TEVA) Receives Approval in Europe for Expanded Trisenox Indication as APL Treatment

November 21, 2016 6:34 AM EST Send to a Friend
Teva Pharmaceutical Industries Ltd., (NYSE: TEVA) announced it has obtained approval from the European Commission for an indication extension of ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login